PEOPLE - International Medical Innovations appoints chairman:
This article was originally published in Clinica
Dr John Bienenstock, a physician and scientist best known for his work in mucosal immunity, has been appointed chairman of the scientific board of International Medical Innovations, a Canadian company which is developing RMT, a mucous test for the early detection of colorectal cancer.
You may also be interested in...
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.
Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.